Checkmate raises $27M in series B

Immuno-oncology play Checkmate Pharmaceuticals Inc. (Cambridge, Mass.) raised $27 million on June 15 in a series B round led by new investor F-Prime Capital Partners. Existing investors Sofinnova Ven...